Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

93
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
93
Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

334
Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
334
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
70
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

72
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
72
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

72
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
72
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

133
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
133

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nutritional and physiological severity scores for predicting 30-day mortality in geriatric intensive care unit patients: a multicenter prospective study.

BMC geriatrics·2026
Same author

Model-Dependent Cardiovascular Risk Stratification in Obese Populations: Multicenter Study in Türkiye.

International journal of general medicine·2026
Same author

Right Atrial Dimension Is Related to Bidirectional Block Parameters After Cavotricuspid Isthmus Ablation in Patients with Typical Atrial Flutter.

Journal of clinical medicine·2026
Same author

Evaluation of the Efficacy of Semaglutide Dose Escalation in Reducing HbA1c Levels and Insulin Dose in Type 2 Diabetes Patients: Real-World Semaglutide Data from Türkiye, SEMA-TR Study.

Journal of clinical medicine·2026
Same author

Ultrasonographic frequency of complex aortic plaques in patients with atrial fibrillation.

BMC cardiovascular disorders·2026
Same author

CHA2DS2-VA Score Can Be Used to Predict In-Hospital Mortality in Patients with Acute Aortic Dissection.

Brazilian journal of cardiovascular surgery·2026

Related Experiment Video

Updated: Jun 5, 2025

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice
06:35

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice

Published on: June 28, 2021

3.9K

Midostaurin-Associated acute pancreatitis.

Mert Akyildiz1, Nebi Cankat Geygel1, Esma Hazal Burhan1

  • 1Department of Internal Medicine, University of Health Sciences - Adana Health Practice and Research Center, Adana, Turkey.

Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|December 5, 2024
PubMed
Summary

Midostaurin, a targeted therapy for FLT3-positive AML, may cause acute pancreatitis, a rare but treatable condition. This case highlights the need to consider drug-induced pancreatitis in patients on midostaurin therapy.

Keywords:
AML FLT3Acute pancreatitismidostaurin

More Related Videos

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
07:10

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct

Published on: April 1, 2022

4.1K
Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
07:38

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection

Published on: May 10, 2024

451

Related Experiment Videos

Last Updated: Jun 5, 2025

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice
06:35

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice

Published on: June 28, 2021

3.9K
Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
07:10

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct

Published on: April 1, 2022

4.1K
Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
07:38

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection

Published on: May 10, 2024

451

Area of Science:

  • Oncology
  • Pharmacology
  • Gastroenterology

Background:

  • Midostaurin is a targeted therapy for FLT3-positive Acute Myeloid Leukemia (AML).
  • While effective, midostaurin has known gastrointestinal side effects.
  • The association between midostaurin and acute pancreatitis is not well-documented.

Purpose of the Study:

  • To report a case of acute pancreatitis in a patient treated with midostaurin for AML FLT3.
  • To highlight the potential link between midostaurin and drug-induced pancreatitis.

Main Methods:

  • A patient with AML FLT3 developed symptoms suggestive of acute pancreatitis after initiating midostaurin.
  • Diagnostic evaluation included clinical presentation, laboratory tests (amylase, lipase), and abdominal imaging.
  • Management involved supportive care including fluid hydration and cessation of oral intake.

Main Results:

  • The patient presented with abdominal pain and elevated pancreatic enzymes.
  • Abdominal imaging showed pancreatic inflammation.
  • Symptoms resolved with supportive treatment, and the patient was discharged.

Conclusions:

  • Drug-induced acute pancreatitis is a rare condition with a generally good prognosis.
  • Potential mechanisms include toxic effects and immune reactions.
  • This case suggests midostaurin as a potential cause of acute pancreatitis, warranting clinical vigilance.